The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21.2 - Manufacture of pharmaceutical preparations
65 jobs Number of planned job losses
Announcement Date
8 July 2013
Employment effect (start)
15 July 2013
Foreseen end date
Description
Aptuit, company operating in the research and development area for the pharmaceutical and biotechnological sectors, is to cut 65 jobs (out of 398) at its Centre for Drug Discovery and Development located at Verona. The largest part of the researchers employed in Aptuit Centre of Verona were part of the former GlaxoSmithKline Research and Development Centre, acquired by Aptuit in 2010.
The trade unions reacted to the company’s decision requiring the involvement of local and national authorities in order to find alternative measures to the job cuts.
Sources
8 July 2013: Libero
Citation
Eurofound (2013), Aptuit, Internal restructuring in Italy, factsheet number 75638, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/75638.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
